X Facebook LinkedIn WhatsApp Press Releases Any 2024 2023 2022 2021 2020 2019 2018 (-) 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2017 March 20, 2017 argenx announces collaboration with Broteio Pharma to develop therapeutic antibody for severe autoimmune diseases March 14, 2017 argenx announces Annual General Meeting of Shareholders 26 April 2017 March 14, 2017 argenx reports fourth quarter business update and full year 2016 financial results March 8, 2017 argenx to host conference call & webcast to report fourth quarter business update and full year 2016 financial results on March 15, 2017 March 2, 2017 argenx announces that Staten Biotech exercised its option to develop therapeutic SIMPLE AntibodyTM for dyslipidemia February 28, 2017 argenx announces intention to conduct a registered public offering in the United States February 26, 2017 argenx to Present at Cowen & Co 37th Annual Healthcare conference February 25, 2017 argenx announces extension of therapeutic antibody alliance with Shire February 8, 2017 argenx to Present at Leerink Partners 6th Annual Global Healthcare Conference January 5, 2017 argenx launches Phase II proof-of-concept study of ARGX-113 for the treatment of myasthenia gravis Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4